WT1 and sarcoma: DSRCT is characterized by the fusion of the Wilms tumor (WT1) gene and the Ewing sarcoma (EWS) gene to form the t(11;22)(p13;q12) fusion, resulting in the upregulation of growth factors on the EWS gene and loss of tumor suppressor function of WT1 [5].